Diagnosis of metachromatic leukodystrophy in a patient with regression and Phelan-McDermid syndrome
- PMID: 32113700
- DOI: 10.1016/j.braindev.2020.02.003
Diagnosis of metachromatic leukodystrophy in a patient with regression and Phelan-McDermid syndrome
Abstract
Phelan-McDermid syndrome (PMS) is a 22q13.3 deletion syndrome. Most PMS patients show global developmental delay and some of them suffer from developmental regression. The deleted region contains ARSA, which is responsible for metachromatic leukodystrophy (MLD). Here we report an extremely rare case of PMS characterized by unusual, rapidly progressive developmental regression due to additional pathogenic mutation in ARSA. Considering the 1 in 100 chance of an MLD carrier, co-occurrence of PMS and MLD in a patient is possible if either parent carries a heterozygous ARSA mutation. Therefore, MLD should be ruled out in PMS patients with severe neurological phenotype.
Keywords: 22q13.3 deletion syndrome; Metachromatic leukodystrophy; Phelan-McDermid syndrome.
Copyright © 2020 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases